Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Gerosa

Showing results (31-40 of 120) with videos related to

Pageof 12
Sort By:
Annals of the Rheumatic Diseases|April 9, 2013
Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosusNicoletta Ronda, Elda Favari, Maria Orietta Borghi, et al.
Rheumatology (Oxford, England)|August 5, 2021
Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patientsTommaso Schioppo, Lorenza Maria Argolini, Savino Sciascia, et al.
Clinical and Experimental Rheumatology|September 12, 2024
Diagnostic pathway and treatment preferences for systemic lupus erythematosus: a physician-based discrete choice experimentMatteo Piga, Luca Quartuccio, Fabiola Atzeni, et al.
Immunologic Research|July 14, 2016
Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndromeEntela Nuri, Mara Taraborelli, Laura Andreoli, et al.
Journal of Clinical Medicine|July 9, 2022
Long-Term Clinical Outcome in Systemic Lupus Erythematosus Patients Followed for More Than 20 Years: The Milan Systemic Lupus Erythematosus Consortium (SMiLE) CohortMaria Gerosa, Lorenzo Beretta, Giuseppe Alvise Ramirez, et al.
Clinical Immunology (Orlando, Fla.)|September 3, 2021
Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one yearGiuseppe A Ramirez, Lorenza M Argolini, Chiara Bellocchi, et al.
Therapeutic Advances in Musculoskeletal Disease|March 14, 2022
Pregnancy in juvenile idiopathic arthritis: maternal and foetal outcome, and impact on disease activityMaria Gerosa, Cecilia Beatrice Chighizola, Francesca Pregnolato, et al.
The Lancet. Rheumatology|March 10, 2025
Diagnostic, research, and real-life effect of the 2023 EULAR-ACR classification criteria for antiphospholipid syndromeKaren Schreiber, Silvia Aguilera, Olga Amengual, et al.
Journal of Autoimmunity|August 7, 2009
Patients with antiphospholipid syndrome display endothelial perturbationMassimo Cugno, Maria Orietta Borghi, Laura Maria Lonati, et al.
Seminars in Arthritis and Rheumatism|September 14, 2020
COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patientsGiuseppe A Ramirez, Maria Gerosa, Lorenzo Beretta, et al.
Pageof 12

Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
Annals of the Rheumatic Diseases|April 9, 2013
Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosusNicoletta Ronda, Elda Favari, Maria Orietta Borghi, et al.
Rheumatology (Oxford, England)|August 5, 2021
Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patientsTommaso Schioppo, Lorenza Maria Argolini, Savino Sciascia, et al.
Clinical and Experimental Rheumatology|September 12, 2024
Diagnostic pathway and treatment preferences for systemic lupus erythematosus: a physician-based discrete choice experimentMatteo Piga, Luca Quartuccio, Fabiola Atzeni, et al.
Immunologic Research|July 14, 2016
Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndromeEntela Nuri, Mara Taraborelli, Laura Andreoli, et al.
Journal of Clinical Medicine|July 9, 2022
Long-Term Clinical Outcome in Systemic Lupus Erythematosus Patients Followed for More Than 20 Years: The Milan Systemic Lupus Erythematosus Consortium (SMiLE) CohortMaria Gerosa, Lorenzo Beretta, Giuseppe Alvise Ramirez, et al.
Clinical Immunology (Orlando, Fla.)|September 3, 2021
Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one yearGiuseppe A Ramirez, Lorenza M Argolini, Chiara Bellocchi, et al.
Therapeutic Advances in Musculoskeletal Disease|March 14, 2022
Pregnancy in juvenile idiopathic arthritis: maternal and foetal outcome, and impact on disease activityMaria Gerosa, Cecilia Beatrice Chighizola, Francesca Pregnolato, et al.
The Lancet. Rheumatology|March 10, 2025
Diagnostic, research, and real-life effect of the 2023 EULAR-ACR classification criteria for antiphospholipid syndromeKaren Schreiber, Silvia Aguilera, Olga Amengual, et al.
Journal of Autoimmunity|August 7, 2009
Patients with antiphospholipid syndrome display endothelial perturbationMassimo Cugno, Maria Orietta Borghi, Laura Maria Lonati, et al.
Seminars in Arthritis and Rheumatism|September 14, 2020
COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patientsGiuseppe A Ramirez, Maria Gerosa, Lorenzo Beretta, et al.
Pageof 12